Search Results - "Tetreault, Scott A."

'Economies of scale' yield multiple benefits for a private, physician-run oncology practice by Tetreault, Scott A, Harwin, William N, Eagle, David

Get more information

Delayed Onset of Autoimmune Hemolytic Anemia Complicating Cladribine Therapy for Waldenström Macroglobulinemia by Tetreault, Scott A., Saven, Alan

“…Therapeutic options for patients with Waldenström macroglobulinemia (WM) now include the purine nucleoside analogues, fludarabine and cladribine. Both these…”
Get full text

Prognostic and Immune-Related Factors for Response to Duvelisib in the Phase 2 DYNAMOTM Clinical Trial in iNHL by Zinzani, Pier Luigi, Flinn, Ian W., Miller, Carole B., Tetreault, Scott A., Ardeshna, Kirit M., Le, NgocDiep, Pachter, Jonathan A., Sprott, Kam, Lustgarten, Stephanie, Weaver, David T., Wagner-Johnston, Nina D.

“…Introduction: Indolent NHL (iNHL) remains largely incurable, with the majority of patients (pts) eventually becoming refractory to standard therapies,…”
Get full text

DYNAMO: A phase 2 trial of the PI3K-δ,γ inhibitor IPI-145 in patients with refractory indolent non-Hodgkin lymphoma by Wagner-Johnston, Nina, Strickland, Donald K, Wright, David Donald, Tetreault, Scott A., Lunin, Scott D., Essell, James H., Webb, Charles D., Langdon, Robert M., Farber, Charles M., Nimeh, Nadim F., Marris, Mike, Coleman, Teresa A., Kelly, Patrick Francis, Steelman, Lori, Dewar, Karen, Pimental, Patricia, Flinn, Ian

“…Abstract only…”
Get full text

Treatment of Hairy Cell Leukemia-Variant with Cladribine by Ietreault, Scott A., Robbins, Bruce A., Saven, Alan

“…Hairy cell leukemia-variant (HCL-V) is an extremely rare chronic B-cell lymphoproliferative disorder clinically and morphologically distinct from classic hairy…”
Get full text